Atlas Trials

Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection

Clinical trial NCT04443868 · WITHDRAWN

Trial details

NCT number
NCT04443868
Sponsor
Sanotize Research and Development corp.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
SARS-CoV Infection
Start date
2021-01-01
Primary completion
2021-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.